Dan‐ni Ren

478 total citations
21 papers, 272 citations indexed

About

Dan‐ni Ren is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Dan‐ni Ren has authored 21 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Cardiology and Cardiovascular Medicine and 5 papers in Cancer Research. Recurrent topics in Dan‐ni Ren's work include Cardiac Fibrosis and Remodeling (6 papers), Signaling Pathways in Disease (5 papers) and Wnt/β-catenin signaling in development and cancer (5 papers). Dan‐ni Ren is often cited by papers focused on Cardiac Fibrosis and Remodeling (6 papers), Signaling Pathways in Disease (5 papers) and Wnt/β-catenin signaling in development and cancer (5 papers). Dan‐ni Ren collaborates with scholars based in China, Japan and United States. Dan‐ni Ren's co-authors include Da Wo, Weidong Zhu, Jingxiao Chen, Hongwei Yan, Jun Peng, Yong Fang, Yan Yin, Shangfeng Liu, Zhongmin Liu and Yihan Chen and has published in prestigious journals such as Nature Communications, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Dan‐ni Ren

19 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan‐ni Ren China 9 174 45 43 31 25 21 272
Hari Priya Vemana United States 11 148 0.9× 51 1.1× 33 0.8× 39 1.3× 26 1.0× 18 337
Rina Fujiwara Japan 11 149 0.9× 55 1.2× 67 1.6× 32 1.0× 33 1.3× 12 325
Yueyang Li China 11 195 1.1× 28 0.6× 41 1.0× 14 0.5× 27 1.1× 18 317
Jale Yüzügülen United Kingdom 7 110 0.6× 62 1.4× 42 1.0× 24 0.8× 25 1.0× 18 266
Qi Shi China 12 129 0.7× 58 1.3× 47 1.1× 53 1.7× 12 0.5× 21 318
Xiaoling Fu China 10 104 0.6× 53 1.2× 34 0.8× 11 0.4× 27 1.1× 21 269
Kah Yong Goh United States 8 220 1.3× 30 0.7× 38 0.9× 78 2.5× 21 0.8× 8 319
Luguo Sun China 12 228 1.3× 42 0.9× 43 1.0× 19 0.6× 25 1.0× 16 372
Shuai Guo China 9 169 1.0× 30 0.7× 51 1.2× 19 0.6× 20 0.8× 17 294
Tiantian Zhao China 11 142 0.8× 59 1.3× 62 1.4× 22 0.7× 22 0.9× 32 323

Countries citing papers authored by Dan‐ni Ren

Since Specialization
Citations

This map shows the geographic impact of Dan‐ni Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan‐ni Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan‐ni Ren more than expected).

Fields of papers citing papers by Dan‐ni Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan‐ni Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan‐ni Ren. The network helps show where Dan‐ni Ren may publish in the future.

Co-authorship network of co-authors of Dan‐ni Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Dan‐ni Ren. A scholar is included among the top collaborators of Dan‐ni Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan‐ni Ren. Dan‐ni Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Xinxin, et al.. (2025). Baicalin Prevents Chronic β‐AR Agonist‐Induced Heart Failure via Preventing Oxidative Stress and Overactivation of the NADPH Oxidase NOX2. Journal of Cellular and Molecular Medicine. 29(4). e70388–e70388. 2 indexed citations
2.
Gong, Yuhang, Da Wo, Canran Wang, et al.. (2025). Qingda granule prevents Ang II-induced cardiac hypertrophy via inhibiting NF-κB signaling pathway. Frontiers in Pharmacology. 16. 1603316–1603316. 1 indexed citations
3.
Chen, Jingxiao, et al.. (2025). Physical and functional interactions between LDLR family members and CXCR4 in breast cancer. FEBS Journal. 292(17). 4580–4590.
4.
Tang, Yirong, Fang Xue, Canran Wang, et al.. (2025). Liensinine Prevents Acute Myocardial Ischemic Injury via Inhibiting the Inflammation Response Mediated by the Wnt/β-Catenin Signaling Pathway. International Journal of Molecular Sciences. 26(10). 4566–4566.
5.
Zhu, Xi, Yuan Meng, Xiaowei Guo, et al.. (2024). Resveratrol protects against myocardial ischemic injury in obese mice via activating SIRT3/FOXO3a signaling pathway and restoring redox homeostasis. Biomedicine & Pharmacotherapy. 174. 116476–116476. 11 indexed citations
6.
Wo, Da, Jingxiao Chen, Xiaohui Zhou, et al.. (2023). Inhibition of a novel Dickkopf-1-LDL receptor–related proteins 5 and 6 axis prevents diabetic cardiomyopathy in mice. European Heart Journal. 45(9). 688–703. 8 indexed citations
7.
Wang, Mengfan, Xiaoxia Ren, Xuelian Li, et al.. (2023). Heterometallic ruthenium–osmium complexes: dual photodynamic and photothermal therapy for melanoma and drug-resistant lung tumourin vivo. Inorganic Chemistry Frontiers. 10(15). 4552–4561. 18 indexed citations
8.
Chen, Jingxiao, et al.. (2023). Resveratrol prevents Ang II-induced cardiac hypertrophy by inhibition of NF-κB signaling. Biomedicine & Pharmacotherapy. 165. 115275–115275. 24 indexed citations
9.
Zhong, Xiaomei, et al.. (2023). Liensinine prevents ischemic injury following myocardial infarction via inhibition of Wnt/β‑catenin signaling activation. Biomedicine & Pharmacotherapy. 162. 114675–114675. 7 indexed citations
10.
Wo, Da, Jingxiao Chen, Rongqiao He, et al.. (2023). Babao Dan Alleviates Cancer Cachexia in Mice Via Inhibiting IL-6/STAT3 Signaling Pathway. Integrative Cancer Therapies. 22. 1563483505–1563483505. 5 indexed citations
11.
12.
Gao, Qian, E. Ma, Jingxiao Chen, et al.. (2022). Qingda granule prevents obesity-induced hypertension and cardiac dysfunction by inhibiting adverse Akt signaling activation. Heliyon. 8(12). e12099–e12099. 5 indexed citations
13.
Xie, Xinxin, Jingxiao Chen, Da Wo, et al.. (2021). Babao Dan is a robust anti-tumor agent via inhibiting wnt/β-catenin activation and cancer cell stemness. Journal of Ethnopharmacology. 280. 114449–114449. 7 indexed citations
14.
He, Rongqiao, Da Wo, Qing Wang, et al.. (2021). Network pharmacology-based analysis in determining the mechanisms of Huoxin pill in protecting against myocardial infarction. Pharmaceutical Biology. 59(1). 1189–1200. 7 indexed citations
15.
Wang, Qing, Da Wo, Jingxiao Chen, et al.. (2021). Huoxin pill prevents acute myocardial ischaemia injury via inhibition of Wnt/β‑catenin signaling. Journal of Cellular and Molecular Medicine. 25(24). 11053–11062. 14 indexed citations
16.
Wo, Da, Jingxiao Chen, Qiongyu Li, et al.. (2020). IGFBP‐4 enhances VEGF‐induced angiogenesis in a mouse model of myocardial infarction. Journal of Cellular and Molecular Medicine. 24(16). 9466–9471. 8 indexed citations
17.
Chen, Jingxiao, Da Wo, Hongwei Yan, et al.. (2019). LRP6 Ectodomain Prevents SDF-1/CXCR4-Induced Breast Cancer Metastasis to Lung. Clinical Cancer Research. 25(15). 4832–4845. 22 indexed citations
18.
Chen, Jingxiao, Da Wo, Hongwei Yan, et al.. (2019). Deletion of low-density lipoprotein-related receptor 5 inhibits liver Cancer cell proliferation via destabilizing Nucleoporin 37. Cell Communication and Signaling. 17(1). 174–174. 30 indexed citations
19.
Ren, Dan‐ni, Jingxiao Chen, Zhi Li, et al.. (2015). LRP5/6 directly bind to Frizzled and prevent Frizzled-regulated tumour metastasis. Nature Communications. 6(1). 6906–6906. 55 indexed citations
20.
Chen, Jingxiao, Hongwei Yan, Dan‐ni Ren, et al.. (2014). LRP6 dimerization through its LDLR domain is required for robust canonical Wnt pathway activation. Cellular Signalling. 26(5). 1068–1074. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hari Priya Vemana Breakdown of academic impact, for papers by Rina Fujiwara Breakdown of academic impact, for papers by Yueyang Li Breakdown of academic impact, for papers by Jale Yüzügülen Breakdown of academic impact, for papers by Qi Shi Breakdown of academic impact, for papers by Xiaoling Fu Breakdown of academic impact, for papers by Kah Yong Goh Breakdown of academic impact, for papers by Luguo Sun Breakdown of academic impact, for papers by Shuai Guo Breakdown of academic impact, for papers by Tiantian Zhao
Rankless by CCL
2026